SALUTE PRESS NEWS

The Mystery of the 2012 Flu Season: Where are the Sick People?

January 26, 2012

An article in the Daily Beast asks: If this is flu season, why is no one getting sick? The commentary notes that while people should be "hacking and sneezing and aching" the Center for Disease Control and Prevention reports that the flu is at "relatively low" levels as of January 2012.

Scriptaid Effects on Cancer Cell Lines

January 16, 2012

Although endocrine therapy for breast cancer has shown excellent results in controlling
the disease, responsiveness to the therapy depends on whether or not there is expression of estrogen receptors in breast cancer cells. Research from the Sbarro Institute for Cancer Research and Molecular Medicine reports on the effectiveness of a new molecule, Scriptaid, that restores receptivity to endocrine therapy in breast cancer cell lines that had tested negative for the expression of estrogen receptors. The findings are reported in the Journal of Cellular Physiology.

Grant Helps Build NeuroAIDS  Research Capacity at Temple University School of Medicine

January 11, 2012

The National Institute of Mental Health (NIMH) has awarded Temple University a five-year, $8.34 million grant to create a Comprehensive NeuroAIDS Core Center (CNAC) at the School of Medicine.

The new center, one of only nine funded by NIMH, will enable researchers to study basic science and clinical aspects of HIV-induced neurological diseases and neurocognitive disorders. Kamel Khalili, Laura H. Carnell Professor and chair of neuroscience, is the principal investigator on the project.

Study Links Birth Defects in Fallujah to U.S. Assaults

January 4, 2012

A dramatic spike in birth defects in the Iraqi city of Fallujah may be caused by genetic damage  from weaponry used in American assaults that took place six years ago, according to a study published in the International Journal of Environmental Research and Public Health.

Novel Evidence Links Pretreatment Fasting Glucose to Slowed Cancer Progression

December 6, 2011

Researchers from the Sbarro Institute for Cancer Research and Molecular Medicine and the Human Health Foundation report that in a multidisciplinary study of 420 non-diabetic, breast and metastatic colorectal cancer patients treated with targeted agents, lower levels of pretreatment fasting glucose were predictive of longer times to disease progression.

Such evidence was particularly significant in breast cancer patients, according to results published in the Annals of Oncology.

Medicare To Cover Obesity Prevention Services

Dec. 2, 2011

Obese patients will now be eligible for fully paid screening and weight loss counseling sessions under Medicare, the Centers for Medicare and Medicaid Services announced.

"I believe this is a great development that should set policy basis for other insurance providers. Innovative counseling programs will likely enhance still insufficient awareness about obesity and its serious health consequences," said Dr. Eva Surmacz, Associate Professor in Biology (Adjunct) and director of the Obesity and Cancer Program at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University’s College of Science and Technology.